Publication | Open Access

Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study

RheumatologyLymphoid NeoplasiaRituximab-induced Serum SicknessAllergyAutoimmune DiseaseLupusMalignant Blood DisorderImmunologyHematologyAutoimmunityAutoantibodiesFrench Nationwide StudyImmunologic DiseaseAutoimmune DiseasesImmunotherapyMedicineInborn Error Of ImmunityHypersensitivity